Therapy of type 2 diabetes, cardiovascular death, and the UGDP
- 15 November 1999
- journal article
- conference paper
- Published by Elsevier in American Heart Journal
- Vol. 138 (5) , S346-S352
- https://doi.org/10.1016/s0002-8703(99)70034-7
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarctionAmerican Heart Journal, 1999
- TREATMENT OF TYPE 2 DIABETES MELLITUSMedical Clinics of North America, 1998
- Sulfonylurea derivatives in cardiovascular research and in cardiovascular patientsCardiovascular Research, 1997
- Role of Sulfonylureas in Non-Insulin-Dependent Diabetes Mellitus: Part II - “The cons”Hormone and Metabolic Research, 1996
- Cardiovascular effects of sulphonylurea derivativesDiabetes Research and Clinical Practice, 1996
- Do Non-Insulin-dependent Diabetes Mellitus and Cardiovascular Disease Share Common Antecedents?Annals of Internal Medicine, 1996
- Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes MellitusAnnals of Internal Medicine, 1996
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Oral Hypoglycemic AgentsNew England Journal of Medicine, 1989
- Effects of Hypoglycemic Agents on Vascular Complications in Patients With Adult-Onset DiabetesPublished by American Medical Association (AMA) ,1978